False-positive mammography results may deter women from continued screening
1. In this cohort study, women were less likely to return for mammogram screening if their...
Read MoreSep 12, 2024
1. In this cohort study, women were less likely to return for mammogram screening if their...
Read MoreSep 10, 2024
1. Median PFS (5.6 months vs 5.6 months) and median OS (21.4 months vs 18.1 months) were similar...
Read MoreSep 10, 2024
1. In a retrospective analysis of 59,875 patients with metastatic prostate cancer, varying...
Read MoreSep 9, 2024
Patients found high value in integrating patient-reported outcomes into electronic health records, but expressed several areas of confusion.
Read MoreSep 3, 2024
An EHR nudge intervention targeting surgeons can reduce sentinel lymph node biopsy (SLNB) among women who meet the Choosing Wisely criteria for SLNB omission.
Read MoreSep 3, 2024
From 1999 to 2020, age-adjusted esophageal cancer mortality decreased among Black adults but stabilized among White adults.
Read MoreSep 3, 2024
Disparities seen in cancer incidence and mortality among men across age groups and countries/territories for 2022 are projected to widen further by 2050.
Read MoreSep 3, 2024
Researchers found an increased risk ratio for depression and anxiety among patients with rare cancers, as well as higher incidences of suicide and PTSD.
Read MoreAug 31, 2024
1. The cumulative incidence of medication-related osteonecrosis of the jaw (MRONJ) in patients...
Read MoreAug 29, 2024
1. Patel and colleagues conducted a secondary economic analysis of a trial that assigned high-risk...
Read MoreAug 29, 2024
1. BrECADD resulted in significantly lower treatment-related morbidity than eBEACOPP. 2....
Read MoreAug 20, 2024
1. The median progression-free survival in the metastasis-directed therapy arm was 10.3 months vs...
Read MoreAug 20, 2024
1. In this modeling study, an alternative set of lung cancer screening criteria was more sensitive...
Read MoreAug 15, 2024
1. In the United States, the estimated annual cost of cancer screening was $43 billion, with...
Read MoreAug 13, 2024
1. When comparing corticosteroid peak dose for immunosuppression for anti–PD-1 plus...
Read MoreAug 11, 2024
1. Approximately 88% of patients with GD2-positive diffuse midline glioma or other progressive CNS...
Read MoreAug 11, 2024
1. Dose-dense adjuvant chemotherapy involving sequential epirubicin/cyclophosphamide and docetaxel...
Read MoreAug 6, 2024
Click here to read this study in the NEJM. ©2024 2 Minute Medicine, Inc. All rights reserved. No...
Read MoreAug 6, 2024
Click here to read this study in NEJM. ©2024 2 Minute Medicine, Inc. All rights reserved. No...
Read MoreAug 6, 2024
1. Median overall survival was 41 months in the TKI-only group vs 40 months in the TKI-SRS group,...
Read More